Viracta Therapeutics, Inc.

CIK 1061027 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Viracta Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 10, 202525-NSE0001354457-25-000630
Feb 14, 2025SCHEDULE 13G0000950170-25-021700
Feb 5, 20258-K0000950170-25-014630
Feb 5, 20258-K0000950170-25-014630
Jan 31, 20258-K0000950170-25-011792
Jan 24, 20258-K0000950170-25-008889
Jan 17, 20258-K0000950170-25-006711
Dec 26, 20248-K0000950170-24-140446
Nov 29, 20248-K0000950170-24-131919
Nov 27, 202440000950170-24-131475
Nov 27, 202440000950170-24-131479
Nov 22, 20248-K0000950170-24-130294
Nov 14, 2024SC 13G/A0000921895-24-002727
Nov 13, 20248-K0000950170-24-125937
Nov 13, 202410-Q0000950170-24-126385
Nov 6, 20248-K0000950170-24-122426
Sep 12, 202440000950170-24-106031
Sep 12, 202440000950170-24-106026
Aug 14, 202410-Q0000950170-24-096982
Aug 14, 20248-K0000950170-24-096648
Jul 29, 20248-K0000950170-24-087020
Jun 24, 202440000950170-24-077005
Jun 24, 202440000950170-24-077000
Jun 24, 202440000950170-24-077012
Jun 24, 202440000950170-24-077008